This Kimball Electronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts initiated coverage on KE, MBX, ENSC, DORM and AGLT, issuing mostly Buy/positive ratings with new price targets.
Stocks · News reference
Investment firm HC Wainwright has initiated research coverage on MBX Biosciences, assigning the stock a 'Buy' rating and a price target of $90.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts initiated coverage on KE, MBX, ENSC, DORM and AGLT, issuing mostly Buy/positive ratings with new price targets.
MBX Biosciences announced its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical and preclinical pipeline.
Microbix Biosystems Inc. is attending and presenting a scientific poster at the Experts in Molecular Diagnostics (EMMD) conference.
Microbix Biosystems Inc. announced a presentation regarding its portfolio of synthetic DNA and RNA quality assessment products (QAPs) used as test controls.
Microbix is assessing the potential impact of new 50% U.S. tariffs on Canadian diagnostic and laboratory reagents, which are scheduled to take effect on October 30, 2026.